EPO906 Therapy in Patients With Advanced Melanoma
Clinical trial NCT00035165 · COMPLETED
Trial details
- NCT number
- NCT00035165
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2003-05-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.